MARKET

IMRN

IMRN

Immuron Ltd
NASDAQ
0.8600
+0.0551
+6.85%
After Hours: 0.8404 -0.0196 -2.28% 16:40 05/11 EDT
OPEN
0.7900
PREV CLOSE
0.8049
HIGH
0.8801
LOW
0.7900
VOLUME
14.25K
TURNOVER
--
52 WEEK HIGH
2.390
52 WEEK LOW
0.6765
MARKET CAP
7.02M
P/E (TTM)
-1.7231
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IMRN last week (0504-0508)?
Weekly Report · 13h ago
Immuron Showcases Oral Antibody Portfolio at Emerging Growth Conference
TipRanks · 3d ago
Immuron files Form 3 for Chairman Paul Gerard Brennan initial beneficial ownership statement
PUBT · 05/04 22:45
Weekly Report: what happened at IMRN last week (0427-0501)?
Weekly Report · 05/04 10:12
Immuron CEO Lydeamore to present at Emerging Growth Conference
PUBT · 04/30 10:17
Immuron files Form 3 for Chief Scientific Officer Jerry Kanellos
PUBT · 04/29 20:03
Immuron files Form 3 for CFO Laurita Aaron James initial beneficial ownership statement
PUBT · 04/29 20:01
Immuron files initial beneficial ownership statement for director Jeannette Anne Joughin
PUBT · 04/29 20:01
More
About IMRN
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.

Webull offers Immuron Ltd - ADR stock information, including NASDAQ: IMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMRN stock methods without spending real money on the virtual paper trading platform.